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 Allergy in Children – A Growing Problem 
 The term ‘allergy’ refers to a familial or hereditary ten-
dency to become sensitized to certain environmental or 
food substances such as dust mites, pollen, mold, or dan-
der and to develop hypersensitivity reactions with an ex-
cessive production of immunoglobulin E (IgE). Allergic 
disorders mainly include atopic dermatitis (AD), allergic 
asthma (AA), allergic rhinitis (AR) and gastrointestinal 
allergies  [1] .
 Allergy represents a global health issue affecting more 
than 20% of the population in Europe and the USA with 
increasing prevalence over the last decade. AD and AA 
are the most frequent chronic diseases in infancy and are 
estimated to affect 5–21% of the children in the industri-
alized Western countries  [2, 3] . Although often trivial-
ized, allergy is one of the major causes of hospitalization 
in children younger than 15 years of age and impacts on 
and impairs family and social life quality and school per-
formance  [4] . The socioeconomic costs accrued by the 
management of the atopic patient are estimated at 10 bil-
lion EUR for direct costs related to hospitalization and 
treatment, and 19 billion EUR for indirect costs related 
to reduced productivity or absenteeism from work or 
school  [2] . Regarding these data it seems imperative to 
understand the pathology of atopy and, moreover, to rec-
ognize and control factors triggering exacerbation of al-
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 Abstract 
 Allergic manifestations are increasingly common in infants 
and children. Accumulating evidence suggests that the ‘epi-
demic’ increase of childhood allergy may be associated with 
environmental factors such as stress. Although the impact of 
stress on the manifestation and exacerbation of allergy has 
been demonstrated, the underlying mechanisms of stress-
induced exacerbation are still obscure. A growing number of 
studies have suggested an altered hypothalamus-pituitary-
adrenal (HPA) axis function to stress in allergic children. It is 
speculated that a dysfunctional HPA axis in response to 
stress may facilitate and/or consolidate immunological aber-
rations and thus, may increase the risk for allergic sensitiza-
tion and exacerbation especially under stressful conditions. 
In the present review the potential impact of a  hypo respon-
sive as well as a  hyper responsive HPA axis on the onset and 
chronification of childhood allergy is summarized. More-
over, potential factors that may contribute to the develop-
ment of an aberrant HPA axis responsiveness in allergy are 
discussed.  Copyright © 2009 S. Karger AG, Basel 
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lergic symptomatology. In general, atopy is described as 
a hereditary condition characterized by distinct immu-
noregulatory abnormalities. In sensitized individuals, 
exposure to environmental allergens leads to hypersecre-
tion of allergen-specific IgE. Cross-binding of IgE mole-
cules located on basophils and mast cells by the allergen 
results in the release of vasoactive and proinflammatory 
mediators being responsible for the acute symptoms of 
atopy such as redness of the skin, edema or pruritus in 
the AD patient or smooth muscle constriction, chest 
tightness or mucus in the AA subject (immediate allergic 
response)  [5] . Allergen-presentation by dendritic cells 
initiates the late-phase response by activating T-helper 
(Th) cells secreting high amounts of interleukin (IL)-4, 
IL-5 and IL-13, reflecting a predominantly Th2 cytokine-
secreting profile. The dominance of Th2 cytokines plays 
a key role in the chronification of allergic inflammation. 
IL-4 and IL-13 stimulate IgE synthesis and induce B cells 
to switch from other Ig isotypes to IgE. They further 
stimulate vascular cell adhesion molecule 1 (VCAM-1) 
expression allowing recruitment and invasion of eosino-
phils into sites of allergic tissue inflammation. IL-5 aug-
ments eosinophil production and stimulates eosinophils 
to secrete toxic proteins (i.e. eosinophil cationic protein) 
which are found to contribute to cell damage of the air-
way system and the skin  [6, 7] . Although the pivotal roles 
of immune dysfunctions in the development of allergic 
disease are undisputed, they cannot explain the rapid in-
crease in the prevalence of allergic conditions.
 One potential hypothesis to explain the increased prev-
alence of allergy is that other factors promoting allergic 
sensitization and subsequent immunopathology may have 
erased and/or increased. Beside other lifestyle factors, e.g. 
nutrition or environment exposure such as pollution, psy-
chosocial stress has been discussed to significantly affect 
the development and maintenance of allergy  [8] . A grow-
ing number of studies suggest that stressful experiences 
such as death of a family member, divorce, unemploy-
ment, or an increase in everyday problems may promote 
the onset and/or the exacerbation of allergic disease  [9–
11] . The importance of stress in triggering exacerbation of 
childhood allergy has been emphasized by others showing 
that high levels of emotional stress induced by divorce, 
moving or parenting difficulties increase the risk to de-
velop AD or AA symptoms  [12, 13] . Based on a survey 
commissioned by the American Psychological Associa-
tion, stress is a growing problem among the general public 
in the USA with 48% of the Americans reporting that 
stress has increased over the past 5 years  [14] . Regarding 
the relevance of stress in triggering atopic disease and fur-
ther, the increase of the everyday stress load in the indus-
trialized countries, it is tempting to speculate that in-
creased life stress is one factor relevant to the ‘epidemic of 
atopy’. Following this idea it may be crucial to better un-
derstand how stress affects allergic inflammatory pro-
cesses and, moreover, which the communicating mole-
cules of the psychoneuroimmunological interplay under 
stressful conditions might be. Since allergic sensitization 
and disease onset usually occur in early childhood, and 
the increase in allergy prevalence is particularly pro-
nounced in infants and children  [2, 15] , research interest 
should be focused on this age group.
 Stress and Hypothalamus-Pituitary-Adrenal Axis 
Function in Allergic Children 
 The hypothalamus-pituitary-adrenal (HPA) axis is 
considered to be a central integrative system being cru-
cial in the successful physiological adaptation of the or-
ganism to stress. During stress corticotrophin-releasing 
hormone (CRH) and arginine vasopressin, the principal 
hypothalamic regulators of the HPA axis are released. 
CRH stimulates the secretion of the adrenocorticotropin 
hormone (ACTH) from the anterior pituitary into the hy-
pophyseal portal system via collateral fibers in the sys-
temic circulation. ACTH leads to the secretion of gluco-
corticoids (GCs; cortisol in humans and corticosterone 
in rodents) from the adrenal cortex, the main target of 
ACTH. GCs are the final effectors of the HPA axis. GCs 
regulate multiple bodily functions and prepare the indi-
vidual to cope with the demand of metabolic, physical 
and psychological stressors  [16] . One important target or-
gan controlled by the HPA axis is the immune system. 
GCs have profound immunosuppressive effects includ-
ing immune functions known to be critically involved in 
allergic inflammation. For example, GCs inhibit dendrit-
ic cell maturation, leading to reduced allergen presenta-
tion to T cells  [17, 18] . GCs further induce apoptosis of 
eosinophils and basophils and have been shown to in-
hibit transmigration of these effector cells to the inflam-
matory site by downregulating leukocyte adhesion 
 molecules, such as endothelial leukocyte adhesion mole-
cule-1 (ELAM-1) or intercellular adhesion molecule-1 
(ICAM-1)  [19, 20] . The potential role of GCs for the al-
lergic inflammation has been further emphasized by data 
showing a close relationship between the circadian 
rhythm of cortisol and changes of basophil and eosino-
phil levels  [21] . Others reported that after treatment with 
the cortisol synthesis inhibitor methyrapone, allergic 
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subjects showed significant exacerbation of the allergic 
skin response  [22] . Regarding the pivotal role of the HPA 
axis both in being highly responsive to stressful (psycho-
social) stimuli, and in orchestrating the adaptive (immu-
nological) response to this stressor, it may be important 
to study HPA axis functioning under stress in allergic 
children.
 Using a laboratory stressor we found that children suf-
fering from allergy show an aberrant HPA axis function. 
In particular, we could demonstrate that AD children 
show significantly attenuated cortisol levels in response 
to a standardized stressor (Trier Social Stress Test (TSST-
C)), when compared to a non-atopic control group  [23] . 
The TSST-C is a standardized psychosocial stress test 
consisting of public speaking (finishing a story in as ex-
citing a manner as possible) and arithmetic tasks (serial 
subtraction) in front of an audience. The TSST-C has 
been repeatedly demonstrated to induce activation of the 
HPA axis and the sympathetic adrenomedullary system 
 [23–25] . Reduced cortisol responses to the stressor in our 
patients could not be explained by previous or concurrent 
treatment with corticosteroids, or differences in person-
ality variables. Trying to further elucidate HPA axis dys-
function in the allergic child, we studied cortisol respons-
es to the TSST-C in AA children. We reported reduced 
cortisol levels after the TSST-C in AA children suggest-
ing that a hyporesponsive HPA axis may not be a charac-
teristic feature limited to skin atopy, but may rather be a 
phenomenon generally linked to allergic inflammation 
regardless of the organ affected  [26] . This idea has been 
confirmed by others showing lower cortisol responses to 
a stressful laboratory procedure, i.e. blood sampling in 
adolescents with different forms of allergy, i.e. AD, AA 
and primarily AR  [27] . It is of note, however, that the data 
suggesting a hyporesponsive HPA axis to stress in allergic 
children have been obtained in studies using standard-
ized acute laboratory stressors. To further emphasize a 
role of a dysfunctional HPA axis in stress-induced disease 
progression, it may be important to study HPA axis re-
sponsiveness in a more ‘naturalistic’ setting including ev-
eryday life stressors as well as chronic stress conditions. 
Wolf et al.  [28] reported that chronic stress and low so-
cioeconomic status are linked to elevated cortisol levels 
in healthy but not in AA children. This observation may 
point to a lower HPA axis responsiveness to chronic home 
stress in allergic children and thus may support the labo-
ratory findings previously discussed.
 These data in aggregate strongly support the idea that 
HPA axis responsiveness to stress may be reduced in the 
chronic allergic child. However, the observation that 
childhood AA and AD are linked to a reduced HPA re-
activity does not necessarily implicate that HPA axis dys-
function is of pathological relevance. Little is known 
about whether a reduced HPA axis response to stressful 
(or other) stimuli increases the risk of allergic sensitiza-
tion or chronification of the disease. Further, it remains 
to be determined whether a hyporesponsive HPA axis is 
key in the stress-allergy relationship in that an inappro-
priate response of the system under stressful conditions 
facilitates or even triggers the (immuno)pathology of al-
lergy. Finally, if a hyporesponsive HPA axis is of patho-
logical relevance, which are the factors that cause aberra-
tion of HPA axis functioning.
 Altered HPA Axis Responsiveness in Allergic 
Children – A Risk Factor in Childhood Allergy? 
 It is well documented that the HPA axis represents a 
major immunoregulatory system that plays a pivotal role 
in balancing the immune response especially under 
stressful conditions. Due to the immunosuppressive and 
anti-inflammatory properties of GCs it has been empha-
sized that an appropriate (re)activity of the HPA axis may 
be essential to control inflammation and to prevent an 
overshooting of the immune response which may be 
damaging for the host. In turn, a chronic failure to raise 
an adequate HPA axis response may contribute to pathol-
ogy  [29] . This idea has been strongly supported by animal 
and human data showing that hyporesponsiveness of the 
HPA axis to stressful or pharmacological stimuli is close-
ly linked to an increased susceptibility to and severity of 
inflammatory disease including allergic inflammation 
such as adult AD  [30–34] . However, data showing a path-
ological significance of HPA axis dysfunction in the pro-
cess of sensitization and/or the manifestation of (child-
hood) allergy are still elusive. Sensitization to environ-
mental allergens is generally observed during the first 
month of life and may or may not be linked to allergic 
symptoms  [35] . Thus, the potential role of an altered HPA 
axis function in the allergic sensitization process, i.e. the 
initiation of a strong infantile specific IgE antibody pro-
duction, is difficult to study. We found that cortisol re-
sponses to stress in newborns at high risk for later devel-
opment of atopic disease by virtue of elevated IgE cord 
blood levels and parental allergies were  increased  [36] . 
This observation has been recently supported by Ball et 
al.  [37] demonstrating a hyperreactive HPA axis to stress 
in 6-month-old infants with an allergic mother. These 
findings may be of relevance suggesting that during the 
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early period of allergy development the HPA axis may be 
rather  hyper - than  hypo reactive to stress. Regarding the 
anti-inflammatory properties of GCs, however, the idea 
that increased levels of endogenous cortisol after stress 
may increase the risk for the inception of the allergic in-
flammatory process appears paradox. It is important to 
recognize that in the last decade, the effect of the HPA 
axis on immunity has been specified in that GCs are not 
totally immunosuppressive but rather shape the immune 
system in a dynamic way by their different, sometimes 
diametrically opposite effects on the different compo-
nents of the immune response. GCs drive a Th2 shift by 
suppressing IL-12, the main Th1 inducer while the secre-
tion of IL-4 and IL-10, which both promote the Th2 re-
sponse, are stimulated. GCs further have a direct stimu-
latory effect on Th2 cells  [38, 39] . As previously discussed, 
the dominance of the Th2-immune response is a key fac-
tor in allergy-inducing IgE hypersecretion and eosino-
phil recruitment and activation  [6] . There are several re-
ports showing that a polarization towards a Th2-domi-
nant immune profile as indicated by high IgE levels or a 
reduced capacity to secrete IFN-  can be already identi-
fied in infants at high risk for later atopic disease  [40, 41] . 
Increased cortisol levels during stress episodes in the pre-
disposed child may lead to an additional shift towards a 
Th2-dominant immune profile that may facilitate the on-
set and/or manifestation of allergic inflammation. An-
other potential detrimental effect of higher stress-in-
duced cortisol levels that may promote manifestation of 
allergic disease involves the induction of IgE secretion by 
GCs. Ray et al.  [42] reported an enhancement of IgE pro-
duction after GC treatment by mononuclear cells in vitro. 
Interestingly, augmentation of IgE secretion was noted 
only in mononuclear cells from atopic, but not in cells 
from non-atopic subjects suggesting an altered sensitivity 
of IgE-producing B cells for GCs in atopics. More recent-
ly, it has been reported that GCs increase IL-4-stimulated 
IgE formation probably via upregulation of the costimu-
latory molecule CD40 ligand (CD40L) on Th cells. Bind-
ing of the CD40L to the B-cell CD40 receptor causes rest-
ing B-cell activation and IgE isotype switching  [43, 44] . 
Regarding these findings, the idea that hyperresponsive-
ness of the HPA axis in infants at high allergic risk may 
promote sensitization and subsequent IgE hyperproduc-
tion does not appear too speculative. Thus, we propose 
that increased cortisol levels to early stress experiences 
may further skew the already Th2-biased immune re-
sponse of the predisposed child towards an even more 
distinct Th2 predominance. Augmentation of Th2-relat-
ed cytokines such as IL-4 and IL-5 may initiate and man-
ifest allergic inflammation by mast cell stimulation, IgE 
isotype switching and eosinophil activation. It has been 
found that GCs and IL-4 act synergistically to induce IgE 
production by B cells. In this study, GCs had an even 
more profound effect on specific IgE formation in sensi-
tized subjects than IL-4  [45] . Thus, elevated levels of en-
dogenous cortisol in stressful situations may be directly 
related to specific IgE hypersecretion.
 It has become clear that hyperresponsiveness of the 
HPA axis in infants predisposed to allergy could contrib-
ute to sensitization and later manifestation of the disease. 
However, it is also evident that this finding contrasts 
sharply with the data reported previously suggesting a 
 hypo responsive HPA axis in children already suffering 
from allergic disease. To explain these diametrical find-
ings, it could be speculated that with the onset or the 
chronification of the disease, the HPA axis may switch 
from a  hyper - to a  hypo active state. To date, no convinc-
ing data are available lending support to this assumption; 
however, there are certain findings that would strength-
en such a hypothetical change in HPA axis functioning. 
A growing body of data suggests that proinflammatory 
cytokines such as IL-1, IL-6 or TNF-  stimulate HPA 
axis activity. It has been proposed that in chronic inflam-
matory conditions, persistently increased levels of endog-
enous cortisol in response to proinflammatory cytokine 
release may lead to  hypo responsiveness of the HPA axis 
probably due to increased negative feedback mechanisms 
 [46] . Accordingly, it may be tempting to speculate that in 
allergic children, manifestation and subsequent long-
term release of pro-inflammatory cytokines drive the 
HPA axis from a  hyper active to a  hypo active response 
profile due to analogous mechanisms. Alternatively, ani-
mal data suggest that chronic stress may result in a change 
of HPA axis responsiveness. Mice subjected to mild stress 
initially showed elevated GC responses; however, after 29 
days of stress exposure significantly blunted GC respons-
es were found  [47] . Most recently, these findings were 
supported by Reber et al.  [48] . Studying the effect of 
chronic stress on experimental colitis in mice he could 
demonstrate an initial rise of GC levels in response to 
subordinate colony housing stress; however, after pro-
longed exposure to the stressful setting (19 days) a sig-
nificant decrease of GC levels was noted. Interestingly, 
attenuated HPA axis responsiveness in response to the 
chronic stressor was linked to higher levels of pro-in-
flammatory and anti-inflammatory cytokines and, fur-
ther, to increased colonic inflammation. Others have em-
phasized that chronic stress during early life potentially 
has a significant effect on the HPA axis and predisposes 
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to HPA axis dysfunction in later life. In this model, early 
life stress is discussed to be linked to hypersecretion of 
CRF resulting in long-term downregulation of adenohy-
pophyseal CRF receptors and depressed ACTH and cor-
tisol responses  [49, 50] . These findings are of specific in-
terest since the allergic child suffers from significant 
(chronic) everyday stress and social problems due to the 
allergic condition and the experience of chronic stress 
exposure in these children generally starts very early in 
life  [51] . It is important to note that the mechanisms dis-
cussed above are mainly built on animal data. To date it 
is still speculative whether these factors are also involved 
in the potential change of an initially  hyper responsive 
into a  hypo responsive HPA axis response in the allergic 
child.
 In a previous section of this overview the potential role 
of a hyperresponsive HPA axis in the sensitization and 
manifestation of childhood allergy has been emphasized. 
The observation that an already established, ongoing al-
lergic inflammation is linked to a suppressed function of 
the HPA axis may likewise be of particular clinical sig-
nificance. As mentioned earlier, GCs are highly effective 
in the clinical management of allergic disease  [29] . The 
failure to rise an appropriate level of endogenous GCs has 
been found to be linked to an increased risk to develop 
chronic inflammatory disease with more severe clinical 
symptoms when stimulated with proinflammatory agents 
 [30–34] . GCs inhibit the transcription of allergy-relevant 
cytokines such as IL-4 and IL-5 which are key cytokines 
in triggering allergic inflammation. GCs further are 
found to inhibit eosinophil transmigration by downregu-
lation of adhesion molecules such as intercellular adhe-
sion molecule-3 and to induce apoptosis of eosinophils 
 [31] . Consequently, a blunted HPA axis reactivity with 
reduced levels of endogenous cortisol in the allergic child 
may facilitate a dysregulation of these parameters, i.e. an 
overshooting of the allergic (inflammatory) response 
leading to exacerbation of allergic symptoms. This effect 
may be expected to be even more pronounced under 
stressful conditions when the HPA axis should be acti-
vated. In fact, the circadian rhythm of cortisol closely 
corresponds with eosinophil levels with highest eosino-
phil levels at the nocturnal nadir of serum cortisol  [52] . 
Others found a close link between low cortisol levels at 
night and high circulating histamine levels and noctur-
nal wheezing in asthmatic subjects  [53] . Landstra et al. 
 [54] reported significantly lower cortisol levels in AA 
children during the night which were associated with 
lower forced expiratory volume in 1 s, nocturnal airway 
obstruction, wheeze and chest tightness supporting a 
close link between endogenous low cortisol levels and al-
lergic symptomatology. Recently, our group found that 
reduced cortisol responses to stress in adult AD patients 
were accompanied by elevated eosinophil and IgE levels, 
increased proinflammatory cytokines as well as exacer-
bation of skin symptomatology 24 h later  [55] . A direct 
causal relationship between a reduced HPA axis function 
and atopic symptoms has been suggested by Laue et al. 
 [55] . Healthy volunteers treated with the GC receptor an-
tagonist RU-486 for 7–14 days developed AD symptom-
atology such as erythema and skin eruptions. None of the 
subjects had a prior history of atopy.
 The data discussed so far strongly support the idea 
that childhood allergy may be initiated or progress in set-
tings of hyper- or hypoactivity of the HPA axis ( fig. 1 ). 
Some potential pathways of how abnormal high or low 
endogenous GC levels under stress may contribute to the 
immunopathology have been discussed. However, these 
concepts are still speculative and have to be confirmed. 
Future studies are needed investigating the HPA axis 
and, importantly, its stress-induced cross-talk through 
allergy-relevant effector cells and cytokines in allergic 
patients at different stages of the disease. Evaluating HPA 
axis responsiveness to stressful stimuli in ‘at-risk babies/
infants’, in infants during the first months of the disease, 
and in children at chronic symptomatic stage may help to 
better understand the role of the HPA axis in the develop-
ment and, further, the stress-induced outburst of allergic 
symptoms. Importantly, besides studying the pathologi-
cal consequences of altered HPA axis function, future re-
search efforts should be focused on identifying factors 
crucial for the development of HPA axis dysfunction. As 
reviewed recently  [56] , genetic factors, i.e. variants of the 
GC receptor gene, may contribute to the interindividual 
differences in HPA axis function including baseline lev-
els of cortisol or the cortisol awakening response. Others 
characterized polymorphisms of the CRH receptor 
(CRHR1) or the ACTH receptor (MC2R) leading to a de-
creased release of ACTH by the pituitary and/or a de-
creased adrenal responsiveness to ACTH resulting in 
lower GC secretion  [57, 58] . Thus, genetic factors are good 
candidates to explain changes in HPA axis function that 
may lead to maladaptive immune development and regu-
lation. The observation that maternal allergy predicts 
higher neonatal cortisol responses to stress and moreover 
a higher risk to develop allergic disease in later life than 
paternal allergy  [34, 59] further points to the relevance of 
the intrauterine environment in the development of HPA 
axis dysfunction in childhood allergy. In recent years a 
concept known as ‘fetal programming’ has gained con-
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siderable interest. It has been proposed that exposure to 
adverse intrauterine (and early extrauterine) influences 
imprints on the fetus a pattern of physiological activity 
resulting in ‘programs’ in the developing brain leading to 
significantly altered physiological functioning and vul-
nerability to various diseases  [60] . Extensive research 
both in animals and humans over the last years has shown 
that the HPA axis is highly susceptible to pre- and post-
natal programming. In animals, stress in utero has been 
linked to altered HPA axis function such as a shift in the 
circadian rhythm of GC secretion or a hyperresponsive-
ness of the HPA axis to stress  [61] . Accordingly, neonatal 
stress, i.e. social isolation or maternal deprivation, were 
found to be associated with long-lasting changes of HPA 
axis function including elevated basal cortisol levels or an 
increased and prolonged HPA axis response to stress  [62, 
63] . Comparable data have been reported also in humans 
suggesting a link between high levels of prenatal or early 
life stress and altered HPA axis functioning in later child-
hood  [64, 65] . These data emphasize that aversive factors 
in utero or in the neonatal environment, independent of 
a genetic influence, affect the developing HPA axis and 
may imprint an altered ‘program’ of HPA axis (re)activity 
leading to a long-term maladaptive behavioral and/or 
HPA Hyperreactivity
Cortisol
HPA Hyporeactivity
Cortisol
Atopic disposition Sensitization/disease onset Chronification
HPA axis function 
IgE
Inflammatory cytokines (IL-4, IL-5)
Leukocyte adhesion (i.e. ICAM-3)
Eosinophilia
Genetic factors
Fetal programming
Chronic stress
Cytokine-mediated HPA axis dysregulation
Immune dysregulation 
Potential factors of
HPA axis dysfunction
development
Atopic history
Th2 shift
 Fig. 1. HPA axis dysfunction – a key factor in atopic disease. Atop-
ic disposition in early infancy is associated with a  hyper respon-
siveness of the HPA axis to stress  [36, 37] . The mechanisms lead-
ing to HPA axis dysfunction in infants predisposed to later  allergy 
are still elusive; however, genetic factors  [56] or fetal program-
ming  [60] have been discussed. We propose that elevated levels of 
endogenous cortisol under stressful conditions in the predisposed 
child skew an already Th2-biased immune response towards an 
even more distinct Th2 dominance increasing the risk for allergic 
sensitization and onset of allergic disease. Cortisol-induced stim-
ulation of IL-4-induced IgE production by B cells may potentiate 
this effect  [43] . During disease progression, HPA axis  hyper re-
sponsiveness switches into HPA axis  hypo responsiveness. Factors 
responsible for the switch in HPA axis functioning are unknown; 
however, dysregulation by chronic inflammatory processes with 
prolonged secretion of proinflammatory cytokines  [46] or chron-
ic stress  [49] due to the allergic condition and related social prob-
lems could be involved. The failure of the chronic allergic child to 
raise an appropriate cortisol response in stressful situations which 
may essential to control the inflammatory response, i.e. the secre-
tion of inflammatory cytokines, leukocyte adhesion and eosino-
phil activation, increases the risk of (stress-induced) exacerbation 
and chronification of the disease. In the aggregate, we propose 
that childhood allergy can be initiated or progress in settings of a 
dysfunctional HPA axis. Due to its important immunoregulatory 
properties, a  hyper reactive as well as a  hypo reactive HPA axis fa-
cilitate immune dysregulation and may initiate and promote an 
atopic disease history. 
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immune response. The imprinting of an altered ‘pro-
gram’ of HPA axis functioning by the intrauterine or the 
early extrauterine environment could be of specific sig-
nificance in the child at high risk for atopy. Pregnancy is 
associated with a strong skewing towards a Th2 cytokine 
pattern which downregulates harmful cytokines and en-
ables the survival of the fetus  [66] . In general, the im-
mune deviation towards Th2-type immunity is convert-
ed to a balanced Th1/Th2-immune response pattern dur-
ing the first years of life  [67] . It is speculated that in 
atopic children the postnatal process of this conversion is 
defective leading to a consolidation of Th2 immunity. 
Following this model we propose that an altered HPA 
axis functioning due to fetal programming additionally 
consolidates and potentiates the Th2 dominance in these 
children and thus increases the risk of immune deviation 
and early allergic sensitization ( fig. 1 ).
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